EUPE:XETRA:XETRA-Ossiam Shiller Barclays Cape Europe Sector Value TR UCITS (EUR)

ETF | Others |

Last Closing

USD 525.2

Change

+0.70 (+0.13)%

Market Cap

USD 0.17B

Volume

1.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.57 (-1.24%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.58 (-0.57%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.28 (-1.19%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.15 (-1.12%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.06 (-1.19%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.33 (-1.39%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.09 (-0.72%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.35 (+0.63%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.04 (+0.37%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.04 (+0.03%)

USD 12.26B

ETFs Containing EUPE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.79% 78% C+ 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.79% 80% B- 73% C
Trailing 12 Months  
Capital Gain -0.51% 27% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.51% 31% F 35% F
Trailing 5 Years  
Capital Gain 73.59% 67% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 73.59% 68% D+ 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 10.29% 68% D+ 68% D+
Dividend Return 10.29% 67% D+ 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.90% 56% F 65% D
Risk Adjusted Return 94.43% 83% B 85% B
Market Capitalization 0.17B 47% F 37% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.